Forecasts data is unavailable for this security.
Share price forecast
The 2 analysts offering 12 month price targets for Cynata Therapeutics Ltd have a median target of 2.49, with a high estimate of 2.99 and a low estimate of 1.99. The median estimate represents a 1,086.67% increase from the last price of 0.21.
High | 1,324.3% | 2.99 |
Med | 1,086.7% | 2.49 |
Low | 849.5% | 1.99 |